CytoDyn(CYDY)
$0.25+0.01 (+3.78%)
CYDY
CytoDyn financials statements
$0.25
At close:+0.01 (+3.78%)
CytoDyn (CYDY) Income Statement
699 Followers
CytoDyn Income Statement
Last quarter (Q1 2027), CytoDyn's total revenue was $0.00. In Q1, CytoDyn's net income was $-19.94M. See CytoDyn’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | May 26 | May 25 | May 24 | May 23 | May 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ -5.92M | $ 0.00 | $ 0.00 | $ 266.00K | |
| $ -17.00K | $ -18.00K | $ -29.00K | $ -175.00K | $ 213.00K | |
| $ 21.79M | $ -11.34M | $ 18.06M | $ 40.40M | $ 72.13M | |
| Depreciation and Amortization | $ 17.00K | $ 18.00K | $ 29.00K | $ 175.00K | $ 781.00K |
| $ -21.79M | $ 8.62M | $ -18.03M | $ -40.40M | $ -194.97M | |
| $ -21.81M | $ 11.32M | $ -18.06M | $ -40.58M | $ -145.40M | |
| $ -20.89M | $ -7.58M | $ -31.78M | $ -39.25M | $ -65.42M | |
| $ -42.70M | $ 3.75M | $ -49.84M | $ -79.82M | $ -210.82M | |
| $ -42.70M | $ 3.75M | $ -49.84M | $ -79.82M | $ -210.82M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.03 | $ 0.00 | $ -0.05 | $ -0.10 | $ -0.43 |
| Diluted EPS | $ -0.03 | $ 0.00 | $ -0.05 | $ -0.10 | $ -0.43 |
| Weighted Average Shares Outstanding | 1.29B | 1.21B | 969.51M | 836.53M | 676.90M |
| Weighted Average Shares Outstanding (Diluted) | 1.29B | 1.24B | 969.51M | 836.53M | 676.90M |
Currency in USD
